| Literature DB >> 26696402 |
Matthias Schiedel1, Tobias Rumpf1, Berin Karaman2, Attila Lehotzky3, Judit Oláh3, Stefan Gerhardt4, Judit Ovádi3, Wolfgang Sippl2, Oliver Einsle4, Manfred Jung1.
Abstract
Sirtuins are NAD(+)-dependent protein deacylases that cleave off acetyl but also other acyl groups from the ε-amino group of lysines in histones and other substrate proteins. Dysregulation of human Sirt2 (hSirt2) activity has been associated with the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of hSirt2 activity a promising strategy for pharmaceutical intervention. The sirtuin rearranging ligands (SirReals) have recently been discovered by us as highly potent and isotype-selective hSirt2 inhibitors. Here, we present a well-defined structure-activity relationship study, which rationalizes the unique features of the SirReals and probes the limits of modifications on this scaffold regarding inhibitor potency. Moreover, we present a crystal structure of hSirt2 in complex with an optimized SirReal derivative that exhibits an improved in vitro activity. Lastly, we show cellular hyperacetylation of the hSirt2 targeted tubulin caused by our improved lead structure.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26696402 DOI: 10.1021/acs.jmedchem.5b01517
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446